Eric R. Manusama

6.4k total citations
14 papers, 546 citations indexed

About

Eric R. Manusama is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eric R. Manusama has authored 14 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eric R. Manusama's work include Virus-based gene therapy research (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and CAR-T cell therapy research (3 papers). Eric R. Manusama is often cited by papers focused on Virus-based gene therapy research (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and CAR-T cell therapy research (3 papers). Eric R. Manusama collaborates with scholars based in Netherlands, Israel and Curacao. Eric R. Manusama's co-authors include A.M.M. Eggermont, Timo L.M. ten Hagen, Sandra T. van Tiel, J. de Ruiter, W. Peter Kingma, Peter H. J. van der Voort, Jan Weel, R. L. Marquet, Johannes H.W. de Wilt and Peet Nooijen and has published in prestigious journals such as Annals of Surgery, British Journal of Cancer and British journal of surgery.

In The Last Decade

Eric R. Manusama

14 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric R. Manusama Netherlands 12 266 162 153 88 81 14 546
Yasunori Yoshimoto Japan 13 199 0.7× 209 1.3× 100 0.7× 118 1.3× 65 0.8× 39 547
Giampiero Macioce Italy 14 87 0.3× 183 1.1× 102 0.7× 66 0.8× 119 1.5× 21 751
Salwa Sheikh Saudi Arabia 16 271 1.0× 181 1.1× 152 1.0× 114 1.3× 39 0.5× 47 690
Lode Goethals Belgium 12 210 0.8× 258 1.6× 161 1.1× 83 0.9× 220 2.7× 31 688
Judith Diment Israel 13 113 0.4× 91 0.6× 89 0.6× 100 1.1× 184 2.3× 28 578
David Cimbaluk United States 14 82 0.3× 193 1.2× 112 0.7× 66 0.8× 63 0.8× 33 536
Kazuyuki Yamaguchi Japan 15 146 0.5× 158 1.0× 165 1.1× 77 0.9× 367 4.5× 52 844
Ki Jung Yun South Korea 13 178 0.7× 237 1.5× 177 1.2× 233 2.6× 52 0.6× 43 687
Mark G. Wahrenbrock United States 6 134 0.5× 219 1.4× 101 0.7× 99 1.1× 150 1.9× 7 753
Piotr Wysocki Poland 10 310 1.2× 189 1.2× 121 0.8× 91 1.0× 120 1.5× 20 548

Countries citing papers authored by Eric R. Manusama

Since Specialization
Citations

This map shows the geographic impact of Eric R. Manusama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric R. Manusama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric R. Manusama more than expected).

Fields of papers citing papers by Eric R. Manusama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric R. Manusama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric R. Manusama. The network helps show where Eric R. Manusama may publish in the future.

Co-authorship network of co-authors of Eric R. Manusama

This figure shows the co-authorship network connecting the top 25 collaborators of Eric R. Manusama. A scholar is included among the top collaborators of Eric R. Manusama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric R. Manusama. Eric R. Manusama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Manusama, Eric R., et al.. (2024). Resuscitative endovascular balloon occlusion of the aorta (REBOA) for non-trauma patients in an urban hospital: a series of two cases. Trauma Surgery & Acute Care Open. 9(1). e001515–e001515. 1 indexed citations
2.
Verberne, C, Zhuozhao Zhan, Edwin R. van den Heuvel, et al.. (2015). Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized “CEAwatch” trial. European Journal of Surgical Oncology. 41(9). 1188–1196. 59 indexed citations
3.
Gietelink, Lieke, D. Henneman, Nicoline J. van Leersum, et al.. (2015). The Influence of Hospital Volume on Circumferential Resection Margin Involvement. Annals of Surgery. 263(4). 745–750. 43 indexed citations
4.
Ruiter, J. de, Jan Weel, Eric R. Manusama, W. Peter Kingma, & Peter H. J. van der Voort. (2009). The Epidemiology of Intra-Abdominal Flora in Critically Ill Patients with Secondary and Tertiary Abdominal Sepsis. Infection. 37(6). 522–527. 94 indexed citations
5.
Wilt, Johannes H. W. de, Eric R. Manusama, Boudewijn van Etten, et al.. (2000). Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions. British Journal of Cancer. 83(9). 1176–1182. 40 indexed citations
6.
Roos, W, Johannes H. W. de Wilt, Eric R. Manusama, et al.. (2000). Isolated Limb Perfusion for Local Gene Delivery. Annals of Surgery. 232(6). 814–821. 22 indexed citations
7.
Bickels, Jacob, Eric R. Manusama, Mordechai Gutman, et al.. (1999). Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremity. European Journal of Surgical Oncology. 25(5). 509–514. 31 indexed citations
8.
Wilt, Johannes H.W. de, Eric R. Manusama, Sandra T. van Tiel, et al.. (1999). Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. British Journal of Cancer. 80(1-2). 161–166. 86 indexed citations
9.
Wilt, Johannes H. W. de, Eric R. Manusama, Sandra T. van Tiel, et al.. (1999). Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. British Journal of Cancer. 80(1-2). 161–166. 2 indexed citations
10.
Manusama, Eric R., Johannes H.W. de Wilt, Timo L.M. ten Hagen, R. L. Marquet, & Alexander M.M. Eggermont. (1999). Toxicity and antitumor activity of interferon gamma alone and in combinations with TNFalpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in rats.. Oncology Reports. 6(1). 173–7. 14 indexed citations
11.
Manusama, Eric R., Peet Nooijen, Timo L.M. ten Hagen, et al.. (1998). Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: The Rotterdam Preclinical-Clinical Program. Seminars in Surgical Oncology. 14(3). 232–237. 12 indexed citations
12.
Manusama, Eric R., et al.. (1998). Assessment of the Role of Neutrophils on the Antitumor Effect of TNFα in anin VivoIsolated Limb Perfusion Model in Sarcoma-Bearing Brown Norway Rats. Journal of Surgical Research. 78(2). 169–175. 19 indexed citations
13.
Manusama, Eric R., et al.. (1996). Isolated limb perfusion with TNFα and melphalan in a rat osteosarcoma model: a new anti-tumour approach. European Journal of Surgical Oncology. 22(2). 152–157. 47 indexed citations
14.
Manusama, Eric R., et al.. (1996). Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the rat. British journal of surgery. 83(4). 551–555. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026